Literature DB >> 23654327

The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome.

P M Savage1, A Sita-Lumsden, S Dickson, R Iyer, J Everard, R Coleman, R A Fisher, D Short, S Casalboni, K Catalano, M J Seckl.   

Abstract

The national registration and treatment service for molar pregnancies in the UK allows for the collection of accurate data on this relatively rare diagnosis. In England and Wales, between 2000 and 2009, 5,793 patients with complete moles and 7,790 with partial moles were registered, compared with a total of 8,242,511 conceptions. The overall molar pregnancy incidence was 1 for every 607 conceptions (complete mole 1:1,423; partial mole 1:1,058), but with major variations with age. For complete moles, the risk varied from < 1:1,000 for ages 18-40, to 1:156 for women aged 45 and 1:8 for those aged 50 and above. The overall risk of requiring chemotherapy after a complete mole was 13.6% and 1.1% for partial mole, while the risk of a further molar pregnancy in the next conception was 1:68 but each of these figures have considerable variations with age. These modern statistics on molar pregnancy risks and outcomes should be of value to clinicians and their patients, while discussing this rare diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23654327     DOI: 10.3109/01443615.2013.771159

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  18 in total

Review 1.  The hydatidiform mole.

Authors:  Jean-Jacques Candelier
Journal:  Cell Adh Migr       Date:  2015-09-30       Impact factor: 3.405

2.  Live euploid birth and complete hydatid mole, followed by partial hydatid mole after ICSI.

Authors:  Ming-Tzeung Chung; Chii-Ruey Tzeng; Ching-Hui Chen; Cindy Chan; Yi-En Chang; Yi-Hua Wu; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

3.  Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.

Authors:  Xing-Zheng Zheng; Xu-Ying Qin; Su-Wen Chen; Peng Wang; Yang Zhan; Ping-Ping Zhong; Natalia Buza; Yu-Lan Jin; Bing-Quan Wu; Pei Hui
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

4.  Clinical presentation and treatment outcome of molar pregnancy: Ten years experience at a Tertiary Care Hospital in Dammam, Saudi Arabia.

Authors:  Ayman A Al-Talib
Journal:  J Family Community Med       Date:  2016 Sep-Dec

5.  Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.

Authors:  Yassemine Khawajkie; Nawel Mechtouf; Ngoc Minh Phuong Nguyen; Kurosh Rahimi; Magali Breguet; Jocelyne Arseneau; Brigitte M Ronnett; Lori Hoffner; Felicia Lazure; Marjolaine Arnaud; Fabrice Peers; Liane Tan; Basam Abu Rafea; Monica Aguinaga; Neil S Horowitz; Asangla Ao; Seang Lin Tan; Richard Brown; William Buckett; Urvashi Surti; Karine Hovanes; Trilochan Sahoo; Philippe Sauthier; Rima Slim
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

Review 6.  A review on management of gestational trophoblastic neoplasia.

Authors:  Seyedeh Reyhaneh Yousefi Sharami; Elham Saffarieh
Journal:  J Family Med Prim Care       Date:  2020-03-26

7.  The genetics of recurrent hydatidiform moles in Mexico: further evidence of a strong founder effect for one mutation in NLRP7 and its widespread.

Authors:  Mónica Aguinaga; Maryam Rezaei; Irma Monroy; Nawel Mechtouf; Javier Pérez; Elsa Moreno; Yolotzin Valdespino; Carolina Galaz; Guadalupe Razo; Daniela Medina; Raúl Piña; Rima Slim
Journal:  J Assist Reprod Genet       Date:  2021-03-22       Impact factor: 3.357

8.  Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition?

Authors:  Valentina E Di Mattei; Letizia Carnelli; Martina Mazzetti; Martina Bernardi; Rossella Di Pierro; Alice Bergamini; Giorgia Mangili; Massimo Candiani; Lucio Sarno
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  A HELLP syndrome complicates a gestational trophoblastic neoplasia in a perimenopausal woman: a case report.

Authors:  Guillaume Vogin; François Golfier; Touria Hajri; Agnès Leroux; Béatrice Weber
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

10.  Are the pituitary gonadotrophins determinants of complete molar pregnancy? An investigation using the method of least squares.

Authors:  Iain H Graham
Journal:  JRSM Short Rep       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.